Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial

By afschroeder • August 26, 2025

Ashfaq A, Choe J, Strugnell SA, Patel N, Sprague SM, Norris KC, Lerma E, Petkovich PM, Bishop CW, Ashfaq A. Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial. Am J Nephrol. 2025;56(4):490-499. doi: 10.1159/000544086. Epub 2025 Feb 21. PMID: 39987904; PMCID: PMC12342699.

Tags: Chronic kidney disease, Extended-release calcifediol, General Internal Medicine, Parathyroid hormone, Progression, Publications, secondary hyperparathyroidism

Incidence and predictors of postoperative recall of propofol injection pain: a prospective observational cohort pilot study

Bellouni G, Clanet M, Touihri K, Delaporte A, Boulos NM, Kim K, Grogan T, Alexander B, Coeckelenbergh S, Joosten A. Incidence and predictors of postoperative[...]

From Insight to Impact: Advancing Learning Health System Capability Through a System-Wide Quality Improvement Symposium

Dermenchyan A, Seiden DS, Bhayani M, Song A, Venkatesan N, Sharma K, Pandrangi K, Han MA. From Insight to Impact: Advancing Learning Health System Capability[...]

Estimating the effects of hypothetical loneliness interventions on memory function among middle-aged and older adults in the United States

Ikesu R, Wu Y, Rojas-Saunero LP, Nianogo RA, Torres JM, Kotwal A, Ramirez CM, Tsugawa Y, Mayeda ER. Estimating the effects of hypothetical loneliness interventions[...]